KEY FEATURES
| Full Name | Phosphatase And Tensin Homolog |
|---|---|
| Synonym | BZS; MHAM; MMAC1; PTEN1; TEP1; Mutated In Multiple Advanced Cancers 1; Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.31-20ng/mL |
| Sensitivity | 0.12ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human PTEN in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human PTEN. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human PTEN and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human PTEN, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human PTEN. You can calculate the concentration of Human PTEN in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human PTEN ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 1.07 | 3.14 | 8.44 | 0.97 | 2.97 | 7.84 |
| Standard deviation | 0.05 | 0.15 | 0.38 | 0.06 | 0.13 | 0.24 |
| CV(%) | 5.09 | 4.9 | 4.56 | 6.63 | 4.4 | 3.05 |
RECOVERY
The recovery of Human PTEN spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 95-108 | 101 |
| EDTA plasma (n=8) | 86-98 | 93 |
| Cell culture media (n=8) | 90-104 | 96 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human PTEN in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with PTEN ELISA Kits
| JUN ELISA Kit | publications with PTEN and JUN |
| PIK3CA ELISA Kit | publications with PTEN and PIK3CA |
| TP53 ELISA Kit | publications with PTEN and TP53 |
| AKT1 ELISA Kit | publications with PTEN and AKT1 |
| PIK3CB ELISA Kit | publications with PTEN and PIK3CB |
| PTK2 ELISA Kit | publications with PTEN and PTK2 |
| PDGFRB ELISA Kit | publications with PTEN and PDGFRB |
| PIK3CD ELISA Kit | publications with PTEN and PIK3CD |
| UBC ELISA Kit | publications with PTEN and UBC |
| SLC9A3R1 ELISA Kit | publications with PTEN and SLC9A3R1 |
Pathways associated with PTEN ELISA Kit
| 3-phosphoinositide Degradation Pathway | 3-phosphoinositide Degradation Pathway |
| Adaptive Immune System Pathway | Adaptive Immune System Pathway |
| Androgen Receptor Signaling Pathway | Androgen Receptor Signaling Pathway |
| BCR Signaling Pathway | BCR Signaling Pathway |
| Central Carbon Metabolism In Cancer Pathway | Central Carbon Metabolism In Cancer Pathway |
| Class I PI3K Signaling Events Pathway | Class I PI3K Signaling Events Pathway |
| D-myo-inositol (1,3,4)-trisphosphate Biosynthesis Pathway | D-myo-inositol (1,3,4)-trisphosphate Biosynthesis Pathway |
Diseases associated with PTEN ELISA Kit
| Carcinoma | publications with PTEN and Carcinoma |
| Adenocarcinoma | publications with PTEN and Adenocarcinoma |
| Skin Diseases | publications with PTEN and Skin Diseases |
| Breast Neoplasms | publications with PTEN and Breast Neoplasms |
| Disease Progression | publications with PTEN and Disease Progression |
| Glioma | publications with PTEN and Glioma |
| Prostatic Neoplasms | publications with PTEN and Prostatic Neoplasms |
| Endometrial Neoplasms | publications with PTEN and Endometrial Neoplasms |
| Neoplasm Metastasis | publications with PTEN and Neoplasm Metastasis |
| Ovarian Neoplasms | publications with PTEN and Ovarian Neoplasms |
Organs/Tissues associated with PTEN ELISA Kit
| Brain | publications with PTEN and Brain |
| Prostate | publications with PTEN and Prostate |
| Blood | publications with PTEN and Blood |
| Lung | publications with PTEN and Lung |
| Vascular | publications with PTEN and Vascular |
| Liver | publications with PTEN and Liver |
| Muscle | publications with PTEN and Muscle |
| Thyroid | publications with PTEN and Thyroid |
| Skin | publications with PTEN and Skin |
| Bone | publications with PTEN and Bone |